Stravitz Visionary Award supports early- to mid-career investigators pursuing innovative basic, translational, and clinical liver disease research with the potential to transform patient care.
Funder: AASLD Foundation
Due Dates: October 12, 2026 (Letter of Intent) | January 11, 2027 (Invited application)
Funding Amounts: $500,000 over three years (July 1, 2027–June 30, 2030)
Summary: Supports innovative liver disease research by early- to mid-career investigators with potential to transform patient care.
Key Information: Full applications are accepted only by invitation following review of a required Letter of Intent.
The AASLD Foundation’s Stravitz Visionary Award supports highly innovative projects that enable early- to mid-career investigators to pursue research with the potential to transform care for patients with liver disease. Basic, translational, and clinical research are eligible, with priority given to innovative or transformative projects with human applications and the potential for broad, sustained impact in hepatology.
Multidisciplinary science is encouraged, and multiple-principal-investigator and multi-institution studies are considered. This is an independent, project-based award rather than a mentored award: applicants must demonstrate their ability to pursue the proposed work independently. The 2027 award is supported through the R. Todd Stravitz AASLD Foundation Research Fund.